Compliance

valeant_logoValeant Pharmaceuticals International, Inc., (NYSE: VRX) (TSX: VRX) completed its acquisition of Bausch + Lomb in August, 2013.

Valeant is committed to the maintenance and ongoing assessment necessary to ensure an effective Compliance Program.
Click here to learn more about the US Healthcare Compliance program at Valeant.com.